63 indexable Biopharma Outsourcing companies headquartered in San Francisco, United States, ranked by total equity funding and recent funding momentum. Combined disclosed equity funding of $1.2B across 22 funded companies.
| # | Company | Funding | Valuation | Stage | Latest round | Employees | Founded | Momentum |
|---|---|---|---|---|---|---|---|---|
| 1 |
Kardigan
Biotech company developing personalized medicines for cardiovascular diseases |
$554M | — | Series B | Series B Oct 2025 | — | 2023 | ↑ Active |
| 2 |
Surrozen
Pioneering targeted regenerative antibodies to repair tissue and restore organ function |
$326M | — | Public | Post IPO Mar 2025 | 80 | 2016 | ↑ Active |
| 3 |
Trial Library
Provider of clinical trial for drug research & development services |
$5M | — | Series A | Series A Dec 2025 | 9 | 2018 | ↑ Active |
| 4 |
Strategikon
Provider of SaaS solutions for clinical trial management |
$2.3M | — | Series A | Venture Debt May 2025 | — | 2017 | ↑ Active |
| 5 |
Anto Biosciences
Developer of microbiology tools to improve food and drug design |
$500K | — | Seed | Seed Sep 2025 | — | 2025 | ↑ Active |
| 6 | Vial | $100M | — | Series B | Series B Dec 2022 | 65 | 2020 | — |
| 7 |
Amber Bio
CDMO focused on manufacturing generic drugs |
$26M | — | Seed | Seed Aug 2023 | 9 | 2021 | — |
| 8 |
64x Bio
Developer of cell lines and production technologies for advanced therapies |
$59.6M | — | Series A | Series A Jan 2022 | 18 | 2017 | — |
| 9 |
AllStripes
Provider of information to patients and communities with the medical data for rare diseases |
$67M | — | Acquired | Series B Aug 2021 | 85 | 2017 | — |
| 10 |
Cromatic
Provider of a digital connectivity platform for matching clients with CROs |
$5.3M | — | Seed | Seed Nov 2023 | 10 | 2022 | — |
| 11 |
Serotiny
Provider of drug research and development services for cell & gene therapies |
$7M | — | Series A | Series A Mar 2023 | 12 | 2009 | — |
| 12 |
SUPERFLUID
Company specializing in translational science and data analysis for molecular diagnostics and tissue and organ health assessment |
$1.9M | — | Series A | Series A Dec 2023 | — | 2015 | — |
| 13 |
Crescendo Health
Platform enabling clinical study participants to assemble and contribute health data |
$3.4M | — | Seed | Seed Jan 2023 | 20 | 2021 | — |
| 14 |
Altheos
R&D company focused on manufacturing drugs for multiple therapeutic areas |
$32.5M | — | Deadpooled | Series A Feb 2012 | — | 2010 | — |
| 15 |
BioSeek
Global leader providing comprehensive laboratory testing services across diverse industries |
$19M | — | Acquired | Series C May 2007 | — | 2000 | — |
| 16 |
BioZone Laboratories
Developer and manufacturer of finished dosage forms |
$6.2M | — | Series A | Series A Jan 2014 | 93 | 1987 | — |
| 17 |
Optivia Biotechnology
CRO offering transporter screening services and solutions for DDI, DMPK, safety and pharmacology |
$2.8M | — | Acquired | Grant (prize money) Sep 2011 | — | 2007 | — |
| 18 |
Validant
Provider of regulatory, compliance, and quality consulting services for GxP product lifecycles |
$2.3M | — | Acquired | Conventional Debt Dec 2018 | 237 | 2005 | — |
| 19 |
Aratome
High-throughput proteomic imaging tool |
$1.2M | — | Funding Raised | Grant (prize money) 2015 | 4 | 2011 | — |
| 20 |
MatterShift
CRO focused on manufacturing of membrane based drugs |
$500K | — | Seed | Seed Nov 2014 | 1 | 2013 | — |
| 21 |
Biomerix Corporation
Innovating health, nutrition, and care solutions with biomaterials and scientific expertise |
$400K | — | Funding Raised | Grant (prize money) Jan 2010 | 13 | 2001 | — |
| 22 |
Synergenics
Consortium provides shared resources and support for independent biotech start-ups |
$99.9K | — | Funding Raised | Grant (prize money) May 2009 | — | 2002 | — |
| 23 |
Blue Matter Consulting
Provider of consulting services focused for clinical drug development |
— | — | Late Stage | PE Sep 2020 | 98 | 2012 | — |
| 24 |
Adaptive Research
Network of community physicians conducting clinical trials |
— | — | Funding Raised | — | — | 2020 | — |
| 25 |
ATOM
Provider of software development services for biopharma companies |
— | — | Unfunded | — | 21 | 2017 | — |
| 26 |
Audacious Ventures
Venture capital fund investing in tech startups |
— | — | Deadpooled | — | — | 2013 | — |
| 27 |
bodygram
Provides body sizing machine |
— | — | Funding Raised | — | 39 | 2003 | — |
| 28 |
Climb Care
CRO focused on providing patient recruitment services for clinical trial |
— | — | Funding Raised | — | 10 | 2020 | — |
| 29 |
Compass Consulting
Provider of recruitment consulting services |
— | — | Unfunded | — | 2 | 2008 | — |
| 30 |
Crescent Bioscience
Provider of biochemical and cell-based compound screening services |
— | — | Unfunded | — | 9 | 2016 | — |
| 31 |
Curify
Research site focused on conducting clinical development services |
— | — | Unfunded | — | 4 | 2020 | — |
| 32 |
DC3 Therapeutics
CRO providing comprehensive discovery and preclinical drug development solutions |
— | — | Unfunded | — | — | 2013 | — |
| 33 |
dQ&A
CRO focused on diabetes research services |
— | — | Unfunded | — | 21 | 2009 | — |
| 34 |
Driver
Company building a global platform to connect cancer patients to potentially life-prolonging therapies |
— | — | Funding Raised | — | 100 | 2014 | — |
| 35 |
Emilien
Specializes in drug discovery and development process |
— | — | Funding Raised | — | 3 | 2004 | — |
| 36 |
evoke giant
Evoke Giant is a creative agency that renders branding, animation, graphic design, social media, digital marketing and advertising services. |
— | — | Acquired | — | 150 | 2002 | — |
| 37 |
Foundery Innovations
Develops and commercializes immunotherapeutics |
— | — | Unfunded | — | — | 2021 | — |
| 38 |
GlobalReach Business Solutions
Strategic intelligence for life science: market insights, competitive analysis, and global development |
— | — | Unfunded | — | — | 2016 | — |
| 39 |
Hawkwood Biotech
Provider of business planning and marketing strategy services |
— | — | Unfunded | — | 12 | 2017 | — |
| 40 |
Headlands Research
Provider of clinical research services |
— | — | Acquired | — | 350 | 2018 | — |
| 41 |
Highline SCIENCES
CRO focused on clinical development services for oncology drugs |
— | — | Acquired | — | 47 | 2018 | — |
| 42 |
IQ Biosciences
Biospecimens and bioservices for preclinical drug discovery and development |
— | — | Unfunded | — | 24 | 2013 | — |
| 43 |
Jupiter Bioventures
Provider of drug development services for peptide & reagents amino acids |
— | — | Funding Raised | — | — | 2020 | — |
| 44 |
Leapfrog Bio
Emerging oncology therapeutics company developing targeted therapies for cancers driven by genetic mutations |
— | — | Unfunded | — | 10 | 2019 | — |
| 45 |
MedicAffairs Consulting
Medical affairs consulting: bridging clinical research and medical practice |
— | — | Unfunded | — | — | 2015 | — |
| 46 |
Neopeutics
Early-stage drug discovery research partner offering robust, cost-effective tools |
— | — | Unfunded | — | 4 | 2009 | — |
| 47 |
Nucleo Life Sciences
Provider of integrated contract drug development services |
— | — | Deadpooled | — | 13 | 2014 | — |
| 48 |
Origintx
Provider of drug discovery services |
— | — | Unfunded | — | 21 | 2018 | — |
| 49 |
Pacific Clinical Research
Full-service clinical research organization |
— | — | Unfunded | — | — | 2016 | — |
| 50 |
Peninsula Pathologists
Premier pathology medical group and CRO services |
— | — | Unfunded | — | — | 2023 | — |
Biotech company developing personalized medicines for cardiovascular diseases. It is a biotechnology company focused on developing precision medicines for cardiovascular disease. The company aims to modernize cardiovascular drug development with a late-stage portfolio of personalized medicines.
Pioneering targeted regenerative antibodies to repair tissue and restore organ function. This company is developing a new class of therapeutics focused on tissue regeneration. Through selective activation of the Wnt pathway with targeted antibodies, they aim to treat serious diseases characterized by tissue injury. They design tissue-specific antibodies that engage the body’s own biological repair mechanisms, devel
Provider of clinical trial for drug research & development services
Provider of SaaS solutions for clinical trial management. These solutions streamline clinical trial processes, focusing on financial management, vendor management, and procurement. The offerings automate budgeting, RFP/RFI management, contract generation, and vendor qualification, improving efficiency and reducing costs. The platform provides real-time insights into trial finances and vendor performance, enabling dat
Developer of microbiology tools to improve food and drug design. The company provides data and tools for other companies. These resources are intended to improve the design of both food and drugs. The tools leverage microbiology to provide insights.
CDMO focused on manufacturing generic drugs
Developer of cell lines and production technologies for advanced therapies. They engineer high yield cell lines and production technologies. The company focuses on accelerating the manufacturing of advanced therapies. Their platform is designed to unlock the scale needed for next generation medicines. The company offers cell line optimization for lentivirus manufacturing and a wide range of biologics.
AllStripes provides information to patients and communities for medical data for rare diseases. It offers patient information like regulatory evidence for drug, medical data science, research in rare diseases, rare disease programs. It offers solutions for diseases like Wilson disease, Sanfilippo syndrome, SURF1 among others.
Provider of a digital connectivity platform for matching clients with CROs. It is an online platform that helps life science innovators find and connect with R&D outsourcing partners for clinical research and development in the life sciences industry. It provides access to a network of CROs that offer non-clinical, preclinical, and clinical services. The features include outsourcing requests management, collaboration
Provider of drug research and development services for cell & gene therapies
Superfluid Dx is a company that is focused on building a translational science and data analysis platform. They specialize in circulating RNA and molecular diagnostics, particularly in relation to tissue and organ health.
HHS
JLABS
Lux Capital
National Science Foundation
_1583293968662.png){kind=logo}
8VC
Bay City Capital
_1583293908314.png){kind=logo}
BoxGroup
Life Science Angels
Spark Capital
Springboard Enterprises
Y Combinator
186 Ventures
Rankings are computed by Radar (Fliar BI) from the Radar company master and are updated periodically. Funding and momentum scores use disclosed equity-funding data only. Figures may lag private rounds. Last updated 2026-06-25.
_1525760402337.jpeg){kind=logo}
_1584093989590.png){kind=logo}
_1583470203394.png){kind=logo}
